Metraipolis › archive › dc_f55eb70f8d42

Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy — Europe PMC PMID:41008798

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41008798
DOI
10.3390/cancers17182953
License (as archived)
solo-consultazione
Archived
2026-11-10T01:41:34.137Z
SHA-256 of the archived text
cdcac5773cb39c4c0b697d4551e010b61ddb2bbb860fd9adf6abf3a91caf85a8
Stable URL of this page
https://metraipolis.com/documento/dc_f55eb70f8d42

How to cite

Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy — Europe PMC PMID:41008798 — Europe PMC (en), https://europepmc.org/article/MED/41008798 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f55eb70f8d42 (Metraipolis archive dc_f55eb70f8d42, sha256 cdcac5773cb39c4c0b697d4551e010b61ddb2bbb860fd9adf6abf3a91caf85a8)
BibTeX
@misc{dcf55eb70f8d42,
  title = {Epigenetic Reprogramming by Decitabine in Triple-Negative Breast Cancer: Mechanisms, Immune Modulation, and Therapeutic Synergy — Europe PMC PMID:41008798},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41008798},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f55eb70f8d42; sha256 cdcac5773cb39c4c0b697d4551e010b61ddb2bbb860fd9adf6abf3a91caf85a8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41008798. Agents can read the archived copy with the MCP tool read_document.